Both in vitro and in vivo analyses demonstrated that high-affinity sPD-1 molecule blocked PD-L1- and PD-L2-mediated immune evasion and reduced tumor growth in immune-competent mouse models of ovarian cancer (111). Here, HOXD13 is linked to neoplasm.